trial · primary record
0.5% AR100DP1
Dermatitis Atopic
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-12-30 |
| Primary endpoint | The change of IGA to 0 or 1 at visit 4 after 14 days treatment |
| Registry ID | NCT07914088 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:39.875Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07914088
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.